Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Get App

Pegaptanib

Confused about any medicine? Just ask Practo AIFREE

50000+ health queries resolved in last month

Chat with Practo AI on Whatsapp

Not finding what you need? Ask Practo AI

FREE

Chat with Practo AI on Whatsapp

Description

Pegaptanib is used for the treatment of a wet type of age-related macular degeneration, an eye disease that impairs central vision. This medicine is not recommended for use in children.

Side effects

Major & minor side effects for Pegaptanib

Blurred vision

Visual disturbances

Eye discomfort

Decreased vision

Swelling or inflammation of the eyelid

Eye irritation

Dryness of eyes

Redness of eye

Small particles or spots in your vision

Uses of Pegaptanib

What is it prescribed for?

Neovascular (Wet) Age-Related Macular Degeneration

This medicine is used for the treatment of a wet type of age-related macular degeneration, an eye disease that impairs central vision making difficult to read, drive, or perform other daily activities.
Concerns

Commonly asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect

    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?

    No habit-forming tendencies were reported.
  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to pegaptanib or any other inactive ingredients present along with it.

Ocular infection or Periocular infections

This medicine is not recommended for use in patients with infectious eye diseases due to the increased risk of worsening of the patient's condition.

Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

General warnings

Thromboembolic events

This medicine may cause serious arterial thromboembolic events in some patients. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Increase in intraocular pressure

This medicine may increase the intraocular pressure and hence should be used with extreme caution in patients with glaucoma (increased intraocular pressure) due to the increased risk of worsening of the patient's condition. It is recommended to monitor the intraocular pressure before and after therapy with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Visual disturbances

This medicine may cause temporary visual disturbances in some patients on therapy. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any such symptoms.

Use in children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. However, it is advised to contact the doctor immediately if you miss a scheduled dose of this medicine.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

Pegloticase

Disease interactions

Disease

Information not available.

Food interactions

Information not available.

Lab interactions

Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works

This medicine works by inhibiting the abnormal blood vessel formation and leakage within the eyes to prevent vision loss.

Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Anti-angiogenic ophthalmic agents

Schedule

Schedule H

Pegaptanib [Internet]. Pubchem.ncbi.nlm.nih.gov. 2018 [cited 7 December 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/56603655#section=Metabolism-Metabolites

[Internet]. Accessdata.fda.gov. 2018 [cited 7 December 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021756s018lbl.pdf

Pegaptanib Injection: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 7 December 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a607057.html
Something doesn’t feel right?
Report an error

Information on this page was last updated on 28 May 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.